Sargramostim biosimilar (Sandoz)
沙格司亭生物类似药（山德士）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameSargramostim biosimilar (Sandoz)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesClariant Produkte (Schweiz) Ag
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthClariant Produkte (Schweiz) Ag
Active IndicationsN/A
Inactive Indications
Other Information
ATC Code
Related LinksN/A